Overview
- The stock climbed roughly 300% from its 2025 low to an intraday high near $8.85, lifting market value to about $700 million before a sharp reversal.
- A regulatory filing that disclosed RichRich Capital’s 5.26% stake on Monday helped trigger a roughly 22% one-day jump as traders piled in.
- Heavy retail buying and elevated short interest produced a short squeeze that amplified gains but then reversed, with shares falling as much as 36% on Tuesday and whipsawing afterward.
- A Form 8-K revealed the company plans to redeem up to $30.5 million of 9.80% first‑lien notes by issuing common stock on June 10, a move that would cut near‑term cash interest but create immediate dilution concerns for shareholders.
- Analysts remain skeptical with an average price target of $3.61 and the company still reporting a roughly $65 million quarterly net loss and negative $55 million adjusted EBITDA, even as glide tests and a small insurer settlement remove some legal and operational overhangs.